INOVIO PHARMACEUTICALS, INC. for INOVIO PHARMACEUTICALS, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to COVID-19 research and development, vaccine distribution and manufacturing; Issues related to Oncology and HPV cancers; Next Generation COVID-19 vaccines and boosters; Issues related to BARDA/ASPR and manufacturing of COVID-19 vaccines and boosters; Continuing Resolution (CR), H.R. 6833, the Continuing Resolution and Ukraine Supplemental Appropriations Act; Prescription Drug User Fee Act (PDUFA); Medical Device User Fees Amendment (MDUFA IV); ARPA-H Act, H.R 5585; Accelerated Approval Integrity Act of 2022, H.R. 6963; Prevent Pandemic Act, S. 3799; DNA Medicines awareness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| COOKAB HASHEMI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.